James R. Baker

ORCID: 0000-0002-7223-2279
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Click Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Chemical Synthesis and Analysis
  • HER2/EGFR in Cancer Research
  • Peptidase Inhibition and Analysis
  • Dendrimers and Hyperbranched Polymers
  • Advanced biosensing and bioanalysis techniques
  • RNA Interference and Gene Delivery
  • Glycosylation and Glycoproteins Research
  • Synthesis and Catalytic Reactions
  • Advanced Fluorescence Microscopy Techniques
  • Radical Photochemical Reactions
  • Photochromic and Fluorescence Chemistry
  • Asymmetric Synthesis and Catalysis
  • Nanofabrication and Lithography Techniques
  • Oxidative Organic Chemistry Reactions
  • Neuroscience and Neuropharmacology Research
  • Synthetic Organic Chemistry Methods
  • Nanoparticle-Based Drug Delivery
  • Cyclization and Aryne Chemistry
  • Optical Imaging and Spectroscopy Techniques
  • Lipid Membrane Structure and Behavior
  • Chemical synthesis and alkaloids
  • Fluorine in Organic Chemistry
  • Protein Degradation and Inhibitors

University College London
2016-2025

University of Michigan
2010-2025

Michigan Medicine
2000-2024

University of Tennessee at Knoxville
2020-2021

The Gordon Hospital
2019-2021

University College Lahore
2017-2021

Transnational Press London
2015-2020

Weatherford College
2019

Institute of Structural and Molecular Biology
2013

The London College
2012

Abstract Prior studies suggested that nanoparticle drug delivery might improve the therapeutic response to anticancer drugs and allow simultaneous monitoring of uptake by tumors. We employed modified PAMAM dendritic polymers <5 nm in diameter as carriers. Acetylated dendrimers were conjugated folic acid a targeting agent then coupled either methotrexate or tritium fluorescein 6-carboxytetramethylrhodamine. These conjugates injected i.v. into immunodeficient mice bearing human KB...

10.1158/0008-5472.can-04-3921 article EN Cancer Research 2005-06-15

The maleimide motif is widely used for the selective chemical modification of cysteine residues in proteins. Despite widespread utilization, there are some potential limitations, including irreversible nature reaction and, hence, and number attachment positions. We conceived a new class which would address these limitations provide opportunities protein modification. report herein use mono- dibromomaleimides reversible illustrate this on SH2 domain Grb2 adaptor (L111C). After initial with...

10.1021/ja908610s article EN publisher-specific-oa Journal of the American Chemical Society 2010-01-21

Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of great current interest in drug discovery. Nevertheless, although the high effectiveness PROTACs against a wide variety targets has been established, most degraders reported to date display limited intrinsic tissue selectivity and do not discriminate between cells different types. Here, we describe strategy for selective specific cell type. We report design synthesis trastuzumab-PROTAC conjugate...

10.1021/acschembio.0c00285 article EN cc-by ACS Chemical Biology 2020-04-27

Two nontoxic, antimicrobial nanoemulsions, BCTP and 401, have been developed. These emulsions are composed of detergents oils in 80% water. diluted up to 1 : 1000 inactivated 190% Bacillus anthracis spores 4 h was also sporicidal against three other species. This activity is due disruption the spore coat after initiation germination without complete outgrowth. 401 had greater than an onset action <30 min. Mixing or with cereus prior subcutaneous injection mice reduced resulting skin lesion...

10.1086/315124 article EN The Journal of Infectious Diseases 1999-12-01

To investigate the uptake of a poly(amidoamine) dendrimer (generation 5 [G5]) nanoparticle covalently conjugated to polyvalent folic acid (FA) as targeting ligand into macrophages, and activity an FA- methotrexate (MTX)-conjugated (G5-FA-MTX) therapeutic for inflammatory disease arthritis.

10.1002/art.30459 article EN Arthritis & Rheumatism 2011-05-26

A series of dibromomaleimides have been shown to be very efficacious at insertion into peptidic disulfide bonds. This conjugation proceeds with a stoichiometric balance reagents in buffered solutions less than 15 min give discrete products while maintaining the bridge and thus peptide conformation. The is initiated by reduction using water-soluble phosphine, tris(2-carboxyethyl)phosphine (TCEP) which allows for subsequent substitution two maleimide bromides generated thiols. Reaction salmon...

10.1021/ja210335f article EN Journal of the American Chemical Society 2011-12-21

The advent of Adcetris™ and Kadcyla™, two recently FDA-approved antibody-drug conjugates (ADCs), in the clinic has had a major impact on treatment lymphoma breast cancer patients, respectively, worldwide. Despite these successes many new ADCs fail at various stages development, often due to shortcomings methods used for their assembly. To address this problem we have developed next generation maleimides (NGMs), which specifically re-bridge reduced interchain disulfide bonds allow efficient...

10.1039/c4ob01550a article EN cc-by Organic & Biomolecular Chemistry 2014-01-01

The introduction of non-natural entities into proteins by chemical modification has numerous applications in fundamental biological science and for the development manipulation peptide protein therapeutics. reduction native disulfide bonds provides a convenient method to access two nucleophilic cysteine residues that can serve as ideal attachment points such modification. optimum bioconjugation strategy utilizing these should include reconstruction bridge mimic role bond, maintaining...

10.1021/bc1004685 article EN publisher-specific-oa Bioconjugate Chemistry 2011-01-27

A next generation maleimide–ADC is shown to have excellent stability in blood serum, as well high potency and selectivity <italic>in vitro</italic>.

10.1039/c5cc03557k article EN cc-by Chemical Communications 2015-01-01

Controlling maleimide hydrolysis allows the modular construction of bromomaleimide-mediated bioconjugates which are either stable or cleavable in an aqueous, thiol-mediated reducing environment.

10.1039/c1cc11114k article EN Chemical Communications 2011-01-01

Bromomaleimides react rapidly and selectively with cysteine to afford thiomaleimides which can be cleaved a phosphine regenerate the or treated base dehydroalanine.

10.1039/b915136b article EN Chemical Communications 2009-01-01

Bromopyridazinedione-mediated bioconjugation to a cysteine containing protein and disulfide peptide is described. The conjugates are cleavable in an excess of thiol, including cytoplasmically-relevant concentrations glutathione, show high level hydrolytic stability. constructs have the potential for four points chemical attachment.

10.1039/c1cc12807h article EN Chemical Communications 2011-01-01

A next-generation disulfide stapling reagent, incorporating both reducing and re-bridging functions, is shown to be successful across various proteins.

10.1039/c5sc02666k article EN cc-by-nc Chemical Science 2015-09-15

Delivering potent, stable, targeted and<italic>in vivo</italic>efficacious antibody–drug conjugates (ADCs) using pyridazinedione functional disulfide re-bridging reagents.

10.1039/c7ra00788d article EN cc-by-nc RSC Advances 2017-01-01

Disulfide bridging offers a convenient approach to generate site-selective antibody conjugates from native antibodies. To optimise the reagents available achieve this strategy, we describe here use of dibromomaleimides designed undergo accelerated post-conjugation hydrolysis. Conjugation and hydrolysis, which serve 'lock' as robustly stable maleamic acids, is achieved in just over 1 h. This dramatic acceleration also shown infer significant improvements homogeneity, demonstrated by mass...

10.1039/c7ob00220c article EN cc-by Organic & Biomolecular Chemistry 2017-01-01

Herein we report novel protocols for the generation and application of dibromopyridazinediones, an exciting class disulfide bridging reagents.

10.1039/c7ob03138f article EN cc-by Organic & Biomolecular Chemistry 2018-01-01

In recent years there has been rising interest in the field of protein–protein conjugation, especially related to bispecific antibodies (bsAbs) and their therapeutic applications. These constructs contain two paratopes capable binding distinct epitopes on target molecules are thus able perform complex biological functions (mechanisms action) not available monospecific mAbs. Traditionally these bsAbs have constructed through protein engineering, but recently chemical methods for construction...

10.1021/acscentsci.2c01437 article EN cc-by ACS Central Science 2023-02-21

Starburst dendrimer, a structurally defined, spherical macromolecule composed of repeating polyamidoamino subunits, was investigated to augment plasmid-mediated gene transfer efficiency in murine cardiac transplantation model. The grafts were directly injected with naked pCH110, plasmid encoding β-galactosidase (β-Gal), or pCH110-dendrimer complex, and reporter expression determined by X-Gal staining. demonstrated widespread extended β-Gal both myocytes the graft infiltrating cells from 7 28...

10.1089/hum.1998.9.4-553 article EN Human Gene Therapy 1998-03-01

We develop a facile approach to fabricating multifunctional dendrimer-stabilized gold nanoparticles (Au DSNPs) for cancer cell targeting and imaging. In this work, amine-terminated generation 5 (G5) poly(amidoamine) (PAMAM) dendrimers pre-functionalized with folic acid (FA) fluorescein isothiocyanate (FI) are complexed Au(III) ions, followed by acetylation of the amine groups on dendrimer surfaces. This one-step process leads spontaneous formation 6 nm-sized Au stabilized bearing both...

10.1039/b902199j article EN The Analyst 2009-01-01
Coming Soon ...